"An estimated one-in-seven people in the U.S. will develop a substance use disorder in their lifetime1, which is why we urgently need to accelerate research efforts focused on improving prevention, treatment and awareness of this public health crisis," said
The annual Pathways program provides funding for up to four research projects with grant amounts of up to
The recipients of the inaugural Pathways program grants include:
Lais Fernanda Berro , Ph.D.,University of Mississippi Medical Center , for preclinical research on quantitative pharmacology and pharmacotherapeutics for opioid and benzodiazepine co-abuseDerek Blevins , M.D.,Columbia University ,New York State Psychiatric Institute , for evaluating the effects of repetitive transcranial magnetic stimulation (rTMS) for the treatment of chronic pain in patients currently treated with prescription opioids who are at risk of developing a moderate or severe opioid use disorderMehdi Farokhnia , M.D., Section on Clinical Psychoneuroendocrinology and Neuropsychopharmacology (CPN),National Institute on Alcohol Abuse and Alcoholism (NIAAA) andNational Institute on Drug Abuse (NIDA),National Institutes of Health (NIH), for examining the neurobiological correlates and safety and efficacy of the GLP-1 system in relation to alcohol useSarah L. Withey , Ph.D.,Harvard Medical School ,McLean Hospital , for assessing the effects of continuous exposure to naltrexone on the behavior and reward circuitry involved in opioid addiction relapses in non-human subjects
"Brain diseases are complicated, and we often don't fully understand the cause or how treatments work," said grant recipient
To qualify, junior investigators must be M.D.s, Ph.D.s, or equivalent, within five years of initial academic appointment or current post-doctoral fellows, and affiliated with a medical or research institution within the U.S. Applicants are evaluated by an independent review committee comprised of specialists in psychiatry, neurobiology, pharmacology and behavioral science from academic research centers focused on SUDs.
"It was a privilege to serve on the Pathways program review committee and have a direct line of sight into the great work being proposed to help combat substance use disorders," said
For more information on the Pathways program, including 2019 program information, visit www.PathwaysResearchAwards.com.
About
Note Regarding Forward-Looking Statements
Certain statements set forth in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including, but not limited to, statements concerning the expected timing, operation and/or potential impact of the ALKERMES PATHWAYS RESEARCH AWARDSSM program, the funding provided by the program and the research supported by such funding. The company cautions that forward-looking statements are inherently uncertain. Although the company believes that such statements are based on reasonable assumptions within the bounds of its knowledge of its business and operations, the forward-looking statements are neither promises nor guarantees and they are necessarily subject to a high degree of uncertainty and risk. Actual performance and results may differ materially from those expressed or implied in the forward-looking statements due to various risks, assumptions and uncertainties. These risks, assumptions and uncertainties include, among others, changes in funding, timing or parameters of the ALKERMES PATHWAYS RESEARCH AWARDSSM program, the nature of any findings or results arising from the research supported by the program and those risks, assumptions and uncertainties described under the heading "Risk Factors" in the company's Annual Report on Form 10-K for the year ended
ALKERMES PATHWAYS RESEARCH AWARDSSM is a service mark of
Alkermes Contacts: |
|
For Investors: |
Eva Stroynowski, +1 781 609 6823 |
Sandy Coombs, +1 781 609 6377 |
|
For Media: |
Sherry Feldberg, +1 781 609 6276 |
1 https://addiction.surgeongeneral.gov/sites/default/files/executive-summary.pdf
View original content to download multimedia:http://www.prnewswire.com/news-releases/alkermes-announces-recipients-of-1st-annual-alkermes-pathways-research-awards-sm-program-300778919.html
SOURCE